Search filters

Filters
Clear All

Phase

  • 20
  • 28
  • 1
  • 27
  • 1
  • 20
  • 8
  • 252
  • 372
  • 175
  • 4
  • 23
  • 346

Found 373 Barrett's Esophagus trials

A listing of Barrett's Esophagus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 CCTG MA.39: Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer
35 years and older
Female
This study will compare the good and bad effects of not giving regional radiotherapy versus using regional radiotherapy in patients with low risk breast cancer as indicated by Oncotype DX Recurrence Score. This is intended to help researchers discover if not giving regional radiotherapy will be as beneficial as using …
99 years and younger
All genders
The study will enrollsubjects who have undergone surgery for stage II or III colorectal cancer and who have residual FFPE tissue available will provide FFPE and whole blood samples. Subjects will receive SIGNATERA test results and may be recommended for adjuvant chemotherapy or observation by their treating clinician.The study also …
99 years and younger
All genders
Phase 3 study to evaluate the efficacy and safety of oral inhalation GB002 seralutinib for the treatment of pulmonary arterial hypertension (PAH). GB002 is a powder taken by inhalation twice a day. The drug is absorbed into the lungs. GB002 will be inhaled using an approved, hand-held device called a …
99 years and younger
All genders
The primary objective of our proposed trial will be to test the hypothesis that a prolonged, unresolved skin inflammation coupled with musculoskeletal power-doppler ultrasound (MSKPDUS) abnormalities driven by IL-23 increase the risk for transition into PsA and that an intervention that targets one of these pivotal molecules (i.e., Guselkumab) will: …
99 years and younger
All genders
TrAVeRse is a multicenter, open-label, randomized, Phase II study of AVR in treatment naive MCL participants. The primary objective is to assess the rate of MRD-negative CR at end of induction after completing 13 cycles of AVR. Participants achieving an MRD-negative CR at end of AVR induction will be randomized …
99 years and younger
All genders
The purpose of this study is to identify the clinical and biological characteristics of HS. Subject over the age of 18 diagnosed with HS will have one initial study visit and then be seen every 6 months during their standard routine clinic visit. First visit will consist of completing a …
99 years and younger
All genders
The primary objective of the study is to gather safety and effectiveness data in support of the Citadel Embolization Device for the treatment of intracranial aneurysms. Secondary objectives are to gain physician experience and expert clinical feedback on the design features of the Citadel Embolization Device to inform possible iterative …
99 years and younger
All genders
This is a prospective cohort study to document long-term dental and other oral outcomes in patients who receive external beam and modern radiation therapy (RT) modalities with curative intent, as part of clinical care for a head and neck cancer. ORARAD II study will examine participants of the original cohort …
99 years and younger
All genders
Assess if cannabis use over time is associated with changes in key Patient Reported Outcomes (PRO) and opioid use over time. We will enroll 600 participants, each site will include 100 cannabis users 100 cannabis non-users diagnosed with cancer in the last 3 years and prescribed opioids. We will collect …
99 years and younger
All genders
This is a phase 3 trial of AOC 1001, an antibody-oligonucleotide conjugate. Protocol includes participants ages 16-65 with a clinical and genetic diagnosis of DM1 with DMPK CTG repeat length greater than or equal to 100; Penn site will enroll ages 18 to 65 years only. Participants will be randomized …
271 - 280 of 373